Paranoid Android: FDA Advisory Committee Continues to Evaluate AI Mental Health Tools
Regulatory expectations for digital health will focus on risk , transparency, and ongoing performance. DHAC discussions and public comments show that ...
Read the original at JDSupra ↗
- Topics
- HealthcareRegulation & Policy
- Mentions
- FDA
- Tracked via
- “AI Risks”